Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?
- PMID: 27075454
- DOI: 10.1007/s40292-016-0144-5
Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?
Abstract
Hypertension, one of the main risk factors for cardiovascular disease, is thought to play a crucial role in the pathophysiology of cognitive impairment. Studies have associated hypertension with subjective cognitive failures and objective cognitive decline. Subjective cognitive failures may reflect the early phase of a long pathological process leading to cognitive decline and dementia that has been associated with hypertension and other cardiovascular risk factors. The underlying cerebral structural change associated with cognitive decline may be a consequence of the cerebral small-vessel disease induced by high blood pressure and may be detected on magnetic resonance imaging as white matter hyperintensities, cerebral microbleeds, lacunar infarcts or enlarged perivascular spaces. The increasing interest in the relationship between hypertension and cognitive decline is based on the fact that blood pressure control in middle-aged subjects may delay or stop the progression of cognitive decline and reduce the risk of dementia in the elderly. Although more evidence is required, several studies on hypertension have shown a beneficial effect on the incidence of dementia.
Keywords: Cognitive impairment; Dementia; Hypertension; Silent brain damage.
Similar articles
-
Treating Hypertension to Prevent Cognitive Decline and Dementia: Re-Opening the Debate.Adv Exp Med Biol. 2017;956:447-473. doi: 10.1007/5584_2016_98. Adv Exp Med Biol. 2017. PMID: 27757933 Review.
-
Blood Pressure Is Not Associated With Cerebral Blood Flow in Older Persons.Hypertension. 2015 Nov;66(5):954-60. doi: 10.1161/HYPERTENSIONAHA.115.05799. Epub 2015 Sep 8. Hypertension. 2015. PMID: 26351027 Clinical Trial.
-
Hypertension and Mild Cognitive Impairment: State-of-the-Art Review.Am J Hypertens. 2024 May 15;37(6):385-393. doi: 10.1093/ajh/hpae007. Am J Hypertens. 2024. PMID: 38214550 Review.
-
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366. Pharmacotherapy. 2008. PMID: 18294116 Review.
-
Subjective cognitive failures in patients with hypertension are related to cognitive performance and cerebral microbleeds.Hypertension. 2014 Sep;64(3):653-7. doi: 10.1161/HYPERTENSIONAHA.114.03621. Epub 2014 Jun 9. Hypertension. 2014. PMID: 24914204
Cited by
-
Treating psychiatric symptoms and disorders with non-psychotropic medications .Dialogues Clin Neurosci. 2019;21(2):193-201. doi: 10.31887/DCNS.2019.21.2/vhede. Dialogues Clin Neurosci. 2019. PMID: 31636493 Free PMC article. Review.
-
Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden.BMC Cardiovasc Disord. 2016 Nov 3;16(1):208. doi: 10.1186/s12872-016-0386-0. BMC Cardiovasc Disord. 2016. PMID: 27809779 Free PMC article. Review.
-
Management of Hypertension in the Elderly and Frail Elderly.High Blood Press Cardiovasc Prev. 2017 Mar;24(1):1-11. doi: 10.1007/s40292-017-0185-4. Epub 2017 Feb 8. High Blood Press Cardiovasc Prev. 2017. PMID: 28181201 Review.
-
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.Nat Rev Neurol. 2023 Nov;19(11):668-687. doi: 10.1038/s41582-023-00879-y. Epub 2023 Oct 10. Nat Rev Neurol. 2023. PMID: 37816937 Free PMC article. Review.
-
Neuroimaging Signatures of Cerebral Small Vessel Disease at Blood Pressure Cutoff Levels of 130/80 and 140/90 mmHg: A Population-Based Study in Community-Dwellers Aged ≥ 60 Years.High Blood Press Cardiovasc Prev. 2018 Jun;25(2):203-208. doi: 10.1007/s40292-018-0254-3. Epub 2018 Feb 23. High Blood Press Cardiovasc Prev. 2018. PMID: 29476452
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical